Surgical management of the patient with metastatic melanoma to the heart

Journal of Cardiac Surgery

Volumn 28, Issue 2, 2013, Pages 124-128

  Judge, Joshua M ^a   Tillou, John D ^b   Slingluff Jr , Craig L ^a   Kern, John A ^a   Kron, Irving L ^a   Weiss, Geoffrey R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; DACARBAZINE; FLUORODEOXYGLUCOSE F 18; INTERFERON; INTERLEUKIN 2; IPILIMUMAB; TEMOZOLOMIDE; VEMURAFENIB;

ADULT; ALGORITHM; ARTIFICIAL EMBOLISM; ASCITES; AXILLARY LYMPH NODE; BRAIN INFARCTION; CANCER CONTROL; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; DRUG MEGADOSE; DRUG UPTAKE; DYSPNEA; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HEART METASTASIS; HEART OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; INTRACRANIAL PRESSURE; JEJUNUM TUMOR; LIVER ANGIOGRAPHY; LIVER FAILURE; LIVER INJURY; LIVER NECROSIS; LUNG LESION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; METASTASIS RESECTION; METASTATIC MELANOMA; MIDDLE CEREBRAL ARTERY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEW YORK HEART ASSOCIATION CLASS; PARALYSIS; PATENT FORAMEN OVALE; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; REPEAT PROCEDURE; REVIEW; SENTINEL LYMPH NODE BIOPSY; SMALL INTESTINE RESECTION; SYSTEMIC THERAPY; THORACOTOMY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TRICUSPID VALVE REPAIR; VALVULAR HEART DISEASE; WEDGE RESECTION; WIDE EXCISION;

ADULT; FATAL OUTCOME; FEMALE; HEART ATRIA; HEART NEOPLASMS; HEART VENTRICLES; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84875209071     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/jocs.12054     Document Type: Review

References (36)

1. Tas F, Mudun A, Kirma C:, Cardiac involvement in melanoma: A case report and review of the literature. J Cancer Res Ther 2010; 6: 359-361.
2. Manola J:, Prognostic factors in metastatic melanoma: A pooled analysis of eastern cooperative oncology group trials. J Clin Oncol 2000; 18: 3782-3793.
3. Glancy DL, Roberts WC:, The heart in malignant melanoma. A study of 70 autopsy cases. Am J Cardiol 1968; 21: 555-571.
4. Petropoulakis PN, Steriotis JD, Melanidis JG, et al. Metastatic malignant melanoma as an intracavitary obstructive mass in the right heart. Eur J Cardiothorac Surg 1998; 14: 538-540.
5. Bussani R, De-Giorgio F, Abbate A, et al. Cardiac metastases. J Clin Pathol 2007; 60: 27-34.
6. Savoia P, Fierro MT, Zaccagna A, et al. Metastatic melanoma of the heart. J Surg Oncol 2000; 75: 203-207.
7. Klatt EC, Heitz DR:, Cardiac metastases. Cancer 1990; 65: 1456-1459.
8. Kontozis L, Soteriou M, Papamichael D, et al. Isolated right atrial metastasis of malignant melanoma mimicking a myxoma. Hellenic J Cardiol 2011; 52: 281-284.
9. Auer J, Schmid J, Berent R, et al. Cardiac metastasis of malignant melanoma mimicking acute coronary syndrome. Eur Heart J 2012; 33: 676.
10. Mindell SM, Chernick AW, Sugarman MH, et al. Right ventricular metastatic melanoma 27 years after resection of the primary tumor. Cancer 1989; 63: 1237-1239.
11. Chen RH, Gaos CM, Frazier OH:, Complete resection of a right atrial intracavitary metastatic melanoma. Ann Thorac Surg 1996; 61: 1255-1257.
12. Pinho T, Rodrigues-Pereira P, Araujo V, et al. Cardiac metastasis of melanoma as first manifestation of disease. Rev Port Cardiol 2009; 28: 633-639.
13. Gibbs P, Cebon JS, Calafiore P, et al. Cardiac metastases from malignant melanoma. Cancer 1999; 85: 78-84.
14. Malouf JF, Thompson RC, Maples WJ, et al. Diagnosis of right atrial metastatic melanoma by transesophageal echocardiographic-guided transvenous biopsy. Mayo Clin Proc 1996; 71: 1167-1170.
15. Tesolin M, Lapierre C, Oligny L, et al. Cardiac metastases from melanoma. Radiographics 2005; 25: 249-253.
16. Endo A, Ohtahara A, Kinugawa T, et al. Characteristics of 161 patients with cardiac tumors diagnosed during 1993 and 1994 in Japan. Am J Cardiol 1997; 79: 1708-1711.
17. Obeid AI, Al Mudamgha A, Smulyan H:, Diagnosis of right atrial mass lesions by transesophageal and transthoracic echocardiography. Chest 1993; 103: 1447-1451.
18. Prabhakar G, Vasilakis A, Hill RC, et al. Right atrial metastatic melanoma in a patient with transient ischemic attacks. Ann Thorac Surg 1998; 65 (3): 844-846.
19. Mousseaux E, Meunier P, Azancott S, et al. Cardiac metastatic melanoma investigated by magnetic resonance imaging. Magn Reson Imaging 1998; 16: 91-95.
20. Houmsse M, Raman SV, Leier CV, et al. Metastatic melanoma of the left ventricle: Cardiac imaging in the diagnosis and surgical approach. Int J Cardiovasc Imaging 2004; 20: 523-526.
21. Canver CC, Lajos TZ, Bernstein Z, et al. Intracavitary melanoma of the left atrium. Ann Thorac Surg 1990; 49: 312-313.
22. Yanagawa B, Kumar P, Tsuneyoshi H, et al. Resection of a mobile cardiac metastatic melanoma. J Card Surg 2010; 25: 178.
23. Onan B:, Surgical resection of solitary metastasis of malignant melanoma to the right atrium. TexHeart Inst J 2010; 37: 598-601.
24. Emmot WW, Vacek JL, Agee K, et al. Metastatic malignant melanoma presenting clinically as obstruction of the right ventricular inflow and outflow tracts. Characterization by magnetic resonance imaging. Chest 1987; 92: 362-364.
25. Leja MJ, Kim M, Perryman L, et al. Metastatic melanoma to the intracavitary left ventricle treated using cardiac autotransplantation technique for resection. Methodist Debakey Cardiovasc J 2011; 7: 44-46.
26. Middleton MR, Grob JJ, Aaronson N, et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000; 18: 158-166.
27. Atallah E, Flaherty L:, Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 2005; 6: 185-193.
28. Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 1999; 17: 2105-2116.
29. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-723.
30. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507-2516.
31. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954.
32. Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600 - mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012; 366: 707-714.
33. Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 2011; 364: 2517-2526.
34. Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366: 2455-2465.
35. Flaherty KT, Robert C, Hersey P, et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 2012; 367: 107-114.
36. Magnuson WJ, Halligan JB:, Successful treatment of melanoma metastatic to the left atrium using external beam radiation therapy. Oncology 2010; 24: 650-653.